Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
S/G2 Phase Transition	8/29	6.824299698598978E-8	4.449443403486534E-5	0	0	19.126739926739926	315.59486231240106	CDKN1C;CCNA2;CDKN1A;CCNB1;KAT5;CCP110;BTRC;RBX1
EZH2 Methyltransferase Role in Cancer	7/28	9.675468035326644E-7	2.620097366408474E-4	0	0	16.69309462915601	231.17435498351625	CDKN1C;CDKN1A;CCNB1;CDH1;CCNE1;TXNIP;CDC25C
Cell Cycle Overiew	12/107	1.4774797301532287E-6	2.620097366408474E-4	0	0	6.383528770111808	85.6999768557817	CDKN1C;CCNA2;CDKN2D;CCNB2;CCND3;CCNB1;CDKN1A;CDKN2B;CCNE1;BTRC;CDC25C;CENPA
G2/M Phase Transition	7/30	1.607421697183113E-6	2.620097366408474E-4	0	0	15.239964416768597	203.31452266495688	CCNB2;CCNB1;KIF20A;BTRC;CDC25C;CENPA;RBX1
SCF/SKP2 Complex	6/26	9.826014891336191E-6	0.0012813123418302394	0	0	14.986224489795918	172.79831842566477	CDKN1C;CCNA2;CDKN1A;BCL2L11;CCNE1;RBX1
HPV E1 and E2 Expression in Early Phase of Cancer	5/20	3.687237545938609E-5	0.004006798133253288	0	0	16.61323155216285	169.58866378754445	CCNA2;CCNB2;CDKN1A;CDH1;RBX1
G1/S Phase Transition	6/34	5.017490486161776E-5	0.004673433995682111	0	0	10.700072886297376	105.93067405975933	CDKN1C;CCNA2;CDKN1A;CCNB1;CCNE1;RBX1
HPV E4 Contribution to Life Cycle of Virus and Cell	3/8	4.0660389420468286E-4	0.033138217377681654	0	0	29.76759493670886	232.41559008863103	CCNA2;CCNB1;CCNE1
FOXM1 Signaling in Prostate Cancer	3/11	0.0011458780966104123	0.08301250210999876	0	0	18.601898734177215	125.96432056880414	CCNA2;CCNB1;CDKN1A
Genes with Mutations Associated with Osteopetrosis	3/12	0.00150538201817832	0.09815090758522646	0	0	16.534177215189874	107.45079933679885	PLEKHM1;TCIRG1;TNFRSF11A
DREAM Complex and FOXM1/MYBL2 Promote Cell Cycle Progression in Cancer	4/28	0.002166795103963559	0.1284318552531128	0	0	8.281725888324873	50.804298094356746	CCNA2;CDKN1A;CCNB1;CCNE1
G2/M Damage Checkpoint	3/17	0.004321924909294262	0.1942539193269124	0	0	10.626401446654612	57.85070749989131	CDKN1A;CCNB1;CDC25C
Androgen Receptor and Cell Cycle in Prostate Cancer	3/17	0.004321924909294262	0.1942539193269124	0	0	10.626401446654612	57.85070749989131	CDKN1A;CCNB1;CCNE1
G0/G1 Cell Cycle Phase Transition Activation in Cancer	5/54	0.004325411555809211	0.1942539193269124	0	0	5.076855169548735	27.634581675402476	CDKN1C;CCNA2;CDKN1A;CDKN2B;CCNE1
SCF/BTRC Complex	4/34	0.004469031886355347	0.1942539193269124	0	0	6.623350253807106	35.83618942607538	CCNB2;CCNB1;BTRC;RBX1
TP53 Signaling in Hepatocellular Carcinoma	3/19	0.0059801957732790005	0.22935809671634755	0	0	9.297151898734176	47.59492806357425	CDKN1A;CCND3;CCNE1
Osteoclasts Function in Osteopetrosis	3/19	0.0059801957732790005	0.22935809671634755	0	0	9.297151898734176	47.59492806357425	PLEKHM1;TCIRG1;TNFRSF11A
Cell Cycle Dysregulation in Melanoma	4/39	0.007333300539386563	0.2490850305973506	0	0	5.675707034082668	27.897970707251343	CCNA2;CDKN1A;CDKN2B;CCNE1
SCF/CCNF Complex	2/7	0.007764033189056902	0.2490850305973506	0	0	19.794949494949496	96.16887947813868	CCP110;RBX1
G0/G1 Phase Transition	4/40	0.008022677365865587	0.2490850305973506	0	0	5.517766497461929	26.625888854528945	CDKN1C;CCNA2;CDKN1A;CCNE1
Kinetochore Assembly	4/40	0.008022677365865587	0.2490850305973506	0	0	5.517766497461929	26.625888854528945	OIP5;CENPA;NDC80;ZWINT
TP53 Signaling in Pancreatic Neoplasms	3/22	0.009094878743860817	0.2571429257112932	0	0	7.827981345769487	36.791855185038	CDKN1A;CCND3;CCNE1
TNF-alpha/TNFRSF1B Signaling	3/22	0.009094878743860817	0.2571429257112932	0	0	7.827981345769487	36.791855185038	CEBPB;MAPKAPK2;MAP3K14
HPV Infection and Cancer	5/65	0.009465383768513861	0.2571429257112932	0	0	4.143765903307888	19.310421287714362	CCNA2;CCNB2;CDKN1A;CDH1;RBX1
Kruppel-like Factor 6 Signaling in Prostate Cancer	2/9	0.012963843633681194	0.3380970419664055	0	0	14.137806637806637	61.43712606759453	CDKN1A;CDH1
Cell Cycle Dysregulation in Mantle Cell Lymphoma	3/26	0.014482913680393871	0.363186912292954	0	0	6.4652724270776005	27.379043164189863	CCNA2;CCND3;CCNE1
Primary Mediastinal B-cell Lymphoma (PMBL) Subtype	3/29	0.019483951319322866	0.47050134297031515	0	0	5.71840311587147	22.52001021214076	CDKN2B;TNFRSF11A;MAP3K14
SCF/FBXO11 Complex	2/12	0.02285030700241779	0.5159116625836634	0	0	9.894949494949495	37.39094338751276	CDH1;RBX1
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling	6/112	0.024570085822547418	0.5159116625836634	0	0	2.8151713515594916	10.433660130055543	CDKN1C;CCNA2;CDKN1A;CDKN2B;CCNE1;MAP3K14
DNA Damage Checkpoint Impairment in Cancer	3/32	0.02532081779551722	0.5159116625836634	0	0	5.12605848974247	18.844049111297558	CDKN1A;MAPKAPK2;CDC25C
Lipogenesis/Lipolysis Activation in Cancer Cells and Cancer-Associated Adipocytes	3/32	0.02532081779551722	0.5159116625836634	0	0	5.12605848974247	18.844049111297558	CEBPB;DGAT1;AGPAT2
TNF-alpha/TNFRSF1A Signaling	3/32	0.02532081779551722	0.5159116625836634	0	0	5.12605848974247	18.844049111297558	CEBPB;MAPKAPK2;MAP3K14
NGFR -> AP-1/CEBPB/CREB/ELK/SRF/TP53 Signaling	3/34	0.029676584276400728	0.5717796934391188	0	0	4.794855042874643	16.865408514684233	CEBPB;MAPKAPK2;MAP3K14
Genes with Mutations Associated with Aging in Humans	2/14	0.030693695199952693	0.5717796934391188	0	0	8.244949494949495	28.7229141774549	CDKN1A;CDKN2B
SCF/FBXO7 Complex	2/14	0.030693695199952693	0.5717796934391188	0	0	8.244949494949495	28.7229141774549	CCNB1;RBX1
WNT Signaling in Breast Cancer	3/35	0.03199304365330512	0.5794295683876372	0	0	4.644778481012659	15.988427348529646	CCNB1;CDH1;BTRC
Vitamins Insufficiency Causes Homocysteine High Level Synthesis	2/15	0.03495759600801872	0.6160095296548163	0	0	7.610334110334111	25.522164833078214	SLC46A1;CBS
RNA and DNA Metabolism Dysregulation	2/16	0.039435538795766834	0.6592813152523072	0	0	7.066378066378066	22.84622120659932	DDX17;ADARB1
MacrophageR -> CEBPB -> NF-kB Signaling	2/16	0.039435538795766834	0.6592813152523072	0	0	7.066378066378066	22.84622120659932	CEBPB;CBL
Protein Nuclear Import and Export	2/17	0.04411736228254256	0.701573663615067	0	0	6.594949494949495	20.582190220957983	NXF1;NUP50
IL6R -> CEBP/ELK/SRF Signaling	2/17	0.04411736228254256	0.701573663615067	0	0	6.594949494949495	20.582190220957983	CEBPB;MAPKAPK2
Proteins Involved in Adhesion, Migration and Invasion of Endometriotic Cell	2/18	0.0489932230652544	0.7173543046423755	0	0	6.182449494949495	18.646720820808223	CDH3;CDH1
PARK2/PINK1/UCHL1 in Young Onset Parkinson's Disease	2/18	0.0489932230652544	0.7173543046423755	0	0	6.182449494949495	18.646720820808223	CCNE1;RNF41
Osteoclast Activation in Postmenopause	3/42	0.050739936587285116	0.7173543046423755	0	0	3.8097370983446934	11.356986202240764	TNFRSF11A;CBL;MAP3K14
MicroRNAs Role in Melanoma	3/43	0.053769815339829906	0.7173543046423755	0	0	3.7143037974683546	10.857069798362614	CDKN1A;BCL2L11;CDH1
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway	4/72	0.055316884092650086	0.7173543046423755	0	0	2.9163929531203343	8.44201589285738	CDKN1A;CCNB1;CDH1;CCNE1
TGFB Signaling activation by Blocking of Tumor Suppressors	4/73	0.05764570638040938	0.7173543046423755	0	0	2.8739792540278084	8.200725961252042	CDKN1A;CCND3;CEBPB;CDKN2B
Proteins Involved in Prostate Cancer	6/138	0.057979503960047675	0.7173543046423755	0	0	2.25765306122449	6.429041209531031	CDKN1A;CDKN2B;CDH1;GDF15;HOXB13;CLU
Mantle Cell Lymphoma	5/105	0.058708599657933416	0.7173543046423755	0	0	2.4811704834605597	7.034537789872301	CCNA2;CCND3;BCL2L11;CCNE1;MAP3K14
Golgi Transport	2/20	0.059289220959174736	0.7173543046423755	0	0	5.494949494949495	15.525033352532992	SEC23A;SEC16A
SCF/FBXW7 Complex	2/20	0.059289220959174736	0.7173543046423755	0	0	5.494949494949495	15.525033352532992	CCNE1;RBX1
Li-Fraumeni Syndrome	2/20	0.059289220959174736	0.7173543046423755	0	0	5.494949494949495	15.525033352532992	CDKN1A;CCNE1
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling	7/175	0.061186798847626324	0.7173543046423755	0	0	2.0709718670076724	5.785930528113689	CDKN1C;CCNA2;CDKN1A;CDKN2B;CCNE1;MERTK;MAP3K14
MTHFR Activity Regulation	2/21	0.06469118449219419	0.7173543046423755	0	0	5.205475810738968	14.253271245331554	CCNB1;MAP3K14
ERK/MAPK Canonical Signaling	3/47	0.06672641207603765	0.7173543046423755	0	0	3.3759493670886074	9.139216255172546	CEBPB;MAPKAPK2;CDC25C
Apoptosis	4/77	0.06747614377426273	0.7173543046423755	0	0	2.7159446491899035	7.3221356306416165	BCL2L11;CRADD;NOXA1;TNFRSF10B
DNMT and MBD Families Activation in DNA Methylation in Cancer	2/22	0.07025082205516801	0.7173543046423755	0	0	4.944949494949495	13.132219639707378	CDKN1A;CDH1
High Level of Homocystine Effects (Methylation Cycle)	2/23	0.07595975517217837	0.7173543046423755	0	0	4.709235209235209	12.138296824433915	SLC46A1;CBS
Transcription Factors in beta-Cell Neogenesis (Rodent Model)	2/23	0.07595975517217837	0.7173543046423755	0	0	4.709235209235209	12.138296824433915	GDF11;MAFB
CUL4/CRL (SCF4) Complex	2/23	0.07595975517217837	0.7173543046423755	0	0	4.709235209235209	12.138296824433915	CDKN1A;RBX1
Proteins Involved in Endometrial Cancer	3/50	0.07728720120643594	0.7173543046423755	0	0	3.1599784540802585	8.090261873491674	CDH3;CDH1;CCNE1
HIF1 Signaling	2/24	0.08180987489800805	0.7173543046423755	0	0	4.494949494949495	11.252464733056147	USP20;SAT2
Peutz-Jeghers Syndrome	3/52	0.08470860725526652	0.7173543046423755	0	0	3.0306897442521312	7.481372987799227	CDKN1A;CEBPB;STK11IP
Eat me Signal: Apoptotic Cell Initiates Phagocytosis	2/25	0.08779333444189662	0.7173543046423755	0	0	4.299297321036452	10.459200248496733	CD14;MERTK
Lipids Enhance Apoptotic Cell Engulfment and Reduce Inflammation	2/25	0.08779333444189662	0.7173543046423755	0	0	4.299297321036452	10.459200248496733	CD14;MERTK
Lipogenesis Regulation in Adipocyte	2/25	0.08779333444189662	0.7173543046423755	0	0	4.299297321036452	10.459200248496733	DGAT1;AGPAT2
Enterocyte Mediated Mucosal Damage in Celiac Disease	2/25	0.08779333444189662	0.7173543046423755	0	0	4.299297321036452	10.459200248496733	MAP3K14;MICA
Proteins with Altered Expression in Cancer Metabolic Reprogramming	4/85	0.0895385814314434	0.7173543046423755	0	0	2.446700507614213	5.904097931606857	CEBPB;TXNIP;SLC16A3;AGPAT2
Insulin Signaling	3/54	0.09242091495850638	0.7173543046423755	0	0	2.9115413253909157	6.93355025845597	TRIP10;CBL;SH2B2
CD157/ITGB2 Signaling in Myeloid Cell	2/26	0.09390254205417706	0.7173543046423755	0	0	4.119949494949495	9.745731553777215	CEBPB;CBL
Glutamate Overdose and Aura Effect Caused by Mutations in PRRT2 Gene	2/26	0.09390254205417706	0.7173543046423755	0	0	4.119949494949495	9.745731553777215	PRRT2;SYT7
Multiple Myeloma	5/121	0.09422276399190546	0.7173543046423755	0	0	2.137185224181802	5.048231263564381	CCND3;CDKN1A;MAFB;TNFRSF11A;MAP3K14
Proteins with Altered Expression in Muscular Dystrophy, Facioscapulohumeral	1/5	0.09562679916877269	0.7173543046423755	0	0	12.341309823677582	28.968783356610405	CDKN1A
Amyloid beta Clearance in Alzheimer Disease	1/5	0.09562679916877269	0.7173543046423755	0	0	12.341309823677582	28.968783356610405	CLU
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease	3/55	0.09638231871471917	0.7173543046423755	0	0	2.8554040895813046	6.68002515638427	CDH1;MAPKAPK2;MAP3K14
IL6 Expression Targets -> Nociception	2/27	0.10013015392054406	0.7173543046423755	0	0	3.9549494949494948	9.101463575738748	CEBPB;CD14
Adherens Junction Assembly (Nectin)	2/27	0.10013015392054406	0.7173543046423755	0	0	3.9549494949494948	9.101463575738748	KEAP1;BAIAP2
Glutamate Overdose and Aura Effect Caused by Mutations in SLC1A3 Gene	2/27	0.10013015392054406	0.7173543046423755	0	0	3.9549494949494948	9.101463575738748	PRRT2;SYT7
Glutamate Overdose and Aura Effect Overiew	2/27	0.10013015392054406	0.7173543046423755	0	0	3.9549494949494948	9.101463575738748	PRRT2;SYT7
Proteins Involved in Melanoma	8/238	0.10391875311990985	0.7173543046423755	0	0	1.7277146042363434	3.911797946454747	AOC3;CDKN1A;CDKN2B;CDH3;BCL2L11;GDF15;CDH1;TXNIP
CFTR Facilitates Oxidative Stress in Airway Epithelium in CF	3/57	0.10450775128813732	0.7173543046423755	0	0	2.749367088607595	6.209429170530872	KEAP1;MAP3K14;RBX1
Osteoclast Activation in Rheumatoid Arthritis	3/57	0.10450775128813732	0.7173543046423755	0	0	2.749367088607595	6.209429170530872	TNFRSF11A;CBL;MAP3K14
Proteins with Altered Expression in Breast Cancer	2/28	0.10646906738397506	0.7173543046423755	0	0	3.8026418026418027	8.517540351659981	CCNB1;CDH1
NF-kB non-Canonical Signaling	2/28	0.10646906738397506	0.7173543046423755	0	0	3.8026418026418027	8.517540351659981	TNFRSF11A;MAP3K14
Osteoclast Activation in Gout	3/58	0.10866857461717845	0.7173543046423755	0	0	2.699240506329114	5.990836437025115	TNFRSF11A;CBL;MAP3K14
Adipocyte Hypertrophy and Hyperplasia	2/29	0.1129124143598142	0.7173543046423755	0	0	3.6616161616161618	7.986507928557335	DGAT1;AGPAT2
TNFR -> NF-kB Signaling	2/29	0.1129124143598142	0.7173543046423755	0	0	3.6616161616161618	7.986507928557335	TNFRSF10B;MAP3K14
Macrophage Function in Diabetes Mellitus Type 1	2/29	0.1129124143598142	0.7173543046423755	0	0	3.6616161616161618	7.986507928557335	CEBPB;CBL
Ubiquinoine Biosynthesis in Humans	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	COQ7
Ubiquinoine Biosynthesis in Rats	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	COQ7
Vitamin D and Folate in Multiple Sclerosis	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	SLC46A1
Oxidative Stress Protection via AHR-NFE2L2-NQO1 Signaling in Keratinocytes	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	KEAP1
Brain Cell Necrosis in Vascular Dementia	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	ATP8A1
Genes with Mutations Associated with Familial and Sporadic Hemiplegic Migraine	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	PRRT2
Neurons Necrosis Caused by Energy Deficiency	1/6	0.11362829707185776	0.7173543046423755	0	0	9.872544080604534	21.47103306971816	ATP8A1
Adherens Junction Assembly (Cadherins)	2/30	0.11945355478394465	0.7173543046423755	0	0	3.530663780663781	7.502052010080992	CDH3;CDH1
TGF-beta Signaling	3/62	0.1259278707881791	0.7173543046423755	0	0	2.5157262390045054	5.212700465484967	CDKN1A;CEBPB;CDKN2B
Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway	2/31	0.12608607026360788	0.7173543046423755	0	0	3.4087425983977706	7.058791816654293	CCNB1;CDH1
Genes with Mutations in Cancer-Associated Resisting to Cell Death	2/31	0.12608607026360788	0.7173543046423755	0	0	3.4087425983977706	7.058791816654293	BCL2L11;TNFRSF10B
NFKB Non-Canonical Signaling Activation in Cancer	2/31	0.12608607026360788	0.7173543046423755	0	0	3.4087425983977706	7.058791816654293	TNFRSF11A;MAP3K14
Hippo/YAP1 Signaling	2/31	0.12608607026360788	0.7173543046423755	0	0	3.4087425983977706	7.058791816654293	CDH1;MERTK
Follicular Lymphoma	4/97	0.1281775549173627	0.7173543046423755	0	0	2.1296872441460617	4.375099198149376	CDKN1C;CCND3;CDKN2B;MAP3K14
CD8+ T-Cell Response in Celiac Disease	3/63	0.1303884434528603	0.7173543046423755	0	0	2.4736708860759493	5.03945449127535	CBL;BAIAP2;MICA
GPR3 in Oocyte Meiotic Arrest	1/7	0.1312723601890444	0.7173543046423755	0	0	8.226700251889168	16.704158790060834	CCNB1
Immunoglobulin Class-Switch Recombination via Classical non-Homologous End-Joining	1/7	0.1312723601890444	0.7173543046423755	0	0	8.226700251889168	16.704158790060834	MDC1
CDKN2B-AS1 in Epigenetic Regulation of Glaucoma	1/7	0.1312723601890444	0.7173543046423755	0	0	8.226700251889168	16.704158790060834	CDKN2B
GNRH Neurons Development and Migration Impairment in Hypogonadotropic Hypogonadism	1/7	0.1312723601890444	0.7173543046423755	0	0	8.226700251889168	16.704158790060834	HS6ST1
Endosomal Recycling	2/32	0.13280375802858913	0.7173543046423755	0	0	3.294949494949495	6.652116677481473	EHD1;RAB11FIP3
Proteins Involved in Colorectal Neoplasms	4/99	0.1352034925063117	0.7173543046423755	0	0	2.0846379909163772	4.171307010355109	CDKN1A;CDX2;CDH1;GDF15
Natural Killer Cell Activation	3/65	0.13947284988854544	0.7173543046423755	0	0	2.393630053082891	4.7151767057534135	CBL;BAIAP2;MICA
APC/C-CDC20 Complex	2/33	0.1396006248263724	0.7173543046423755	0	0	3.1884978820462693	6.278055440322773	CCNA2;CCNB1
Centriole Duplication and Separation	2/33	0.1396006248263724	0.7173543046423755	0	0	3.1884978820462693	6.278055440322773	PLK4;CCP110
Proteins Involved in Acute Myeloid Leukemia	2/34	0.14647088113096834	0.7173543046423755	0	0	3.088699494949495	5.933171301337038	CDKN1A;CDKN2B
Proteins Involved in Breast Cancer Related to WNT Signaling Pathway	2/34	0.14647088113096834	0.7173543046423755	0	0	3.088699494949495	5.933171301337038	CCNB1;CDH1
Leukotriene Effect on Vascular Endothelial Cell Response	2/34	0.14647088113096834	0.7173543046423755	0	0	3.088699494949495	5.933171301337038	CDH1;MAP3K14
Monocytes Function in Gout	2/34	0.14647088113096834	0.7173543046423755	0	0	3.088699494949495	5.933171301337038	TXNIP;CD14
CCKBR -> Neurotransmitter Uptake	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	CCK
TAM Receptors in Platelet Aggregation	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	MERTK
Selencompound Biosynthesis	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	PSTK
Metaphase/Anaphase Phase Transition	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	CCNB1
Androgen Receptor/Beta-2-Microglobulin Signaling in Prostate Cancer	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	CCNA2
CXCR4 -> ARRB1 Signaling	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	MAPKAPK2
MYOC in Cell Adhesion in Glaucoma	1/8	0.14856606756285953	0.7173543046423755	0	0	7.0510975170924794	13.444507581714497	SPON2
Proteins Involved in Ulcerative Colitis	5/141	0.15068361729345375	0.7173543046423755	0	0	1.8210223020505911	3.446417440920923	CDH1;TXNIP;CD14;CLDN2;MICA
KRAS Signaling	2/35	0.1534089354261384	0.7173543046423755	0	0	2.994949494949495	5.614476507746642	SPRY2;RASGRP2
NOTCH1 Signaling in Breast Cancer	2/35	0.1534089354261384	0.7173543046423755	0	0	2.994949494949495	5.614476507746642	CCNB1;CDH1
EPCAM in Cancer Cell Motility and Proliferation	2/36	0.16040938860431736	0.7173543046423755	0	0	2.906714200831848	5.3193627156148775	CDH1;CCNE1
Apoptosis Block in Synovial Fibroblast	2/36	0.16040938860431736	0.7173543046423755	0	0	2.906714200831848	5.3193627156148775	TNFRSF10B;MAP3K14
Donohue Syndrome Progression (Hypothesis)	2/36	0.16040938860431736	0.7173543046423755	0	0	2.906714200831848	5.3193627156148775	MAPKAPK2;SH2B2
Apoptosis Evasion in Cancer: Overview	4/106	0.16096152154733762	0.7173543046423755	0	0	1.9408778739922365	3.5451879977769343	BCL2L10;BCL2L11;CRADD;TNFRSF10B
Cholesteatoma	3/70	0.16305843171355835	0.7173543046423755	0	0	2.2144341583223124	4.0162011275261715	CDKN1A;CBL;KLF4
Chronic Myeloid Leukemia	3/70	0.16305843171355835	0.7173543046423755	0	0	2.2144341583223124	4.0162011275261715	CDKN1A;CEBPB;CBL
Melanoma	5/145	0.16338892957017961	0.7173543046423755	0	0	1.7686295892402764	3.204088007256736	CCNA2;CDKN1A;CDKN2B;CDH1;CCNE1
Acetylases Inhibition in Histone Deacetylation in Cancer	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	KAT5
Visual Cycle in Retinal Cones	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	DHRS3
Vitamin D Activates Transcription	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	CDKN1A
APP Processing in Alzheimer Disease	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	KAT5
CAV1 Dependent Senescence of Lung Fibroblasts	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	CDKN1A
InsulinR -> STAT Signaling	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	SH2B2
Ubiquitin Ligase Complex in Prostata Cell	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	RBX1
Glioblastoma, Mesenchymal Subtype	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	MERTK
MIR155 Role in Th17-Cell in Multiple Sclerosis	1/9	0.1655163585365792	0.7173543046423755	0	0	6.169395465994962	11.096800600982423	MAP3K14
TERT Activation in Cancer	2/37	0.16746702867252802	0.7173543046423755	0	0	2.8235209235209235	5.045543770613904	CEBPB;KLF4
P38 MAPK/MAPK14 Signaling	2/37	0.16746702867252802	0.7173543046423755	0	0	2.8235209235209235	5.045543770613904	MAPKAPK2;TAOK2
Immune System Role in Otitis Media	2/37	0.16746702867252802	0.7173543046423755	0	0	2.8235209235209235	5.045543770613904	TXNIP;CD14
Proteins Involved in Stem Cell Exhaustion in Aging	2/39	0.18173392504540892	0.7173543046423755	0	0	2.6706251706251707	4.5539810519752955	CDKN1A;CCNE1
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation	2/39	0.18173392504540892	0.7173543046423755	0	0	2.6706251706251707	4.5539810519752955	CBL;MAP3K14
TNFR -> AP-1/ATF/TP53 Signaling	2/39	0.18173392504540892	0.7173543046423755	0	0	2.6706251706251707	4.5539810519752955	TNFRSF10B;MAP3K14
MHC2-Mediated Antigen Presentation	1/10	0.18213003557277826	0.7173543046423755	0	0	5.483627204030227	9.338805578008461	IFI30
Arachidonic Acid Metabolism	1/10	0.18213003557277826	0.7173543046423755	0	0	5.483627204030227	9.338805578008461	CYP2U1
Familial Partial Lipodystrophy Type 3 Progression (Hypothesis)	1/10	0.18213003557277826	0.7173543046423755	0	0	5.483627204030227	9.338805578008461	AGPAT2
Nitroxyl and CGRP in Migraine Pain Activation	1/10	0.18213003557277826	0.7173543046423755	0	0	5.483627204030227	9.338805578008461	CBS
B-Cell Acute Lymphoblastic Leukemia	3/74	0.18271709779040904	0.7173543046423755	0	0	2.0892494205740775	3.5513400861701934	CDKN1A;CCND3;CDKN2B
Invadopodia Formation in Cancer Cells	3/75	0.18772787585235873	0.7173543046423755	0	0	2.060126582278481	3.446101119256676	SH3PXD2A;IQSEC1;TRIP10
Proteins Involved in Osteopetrosis	2/40	0.18893364567227594	0.7173543046423755	0	0	2.600212652844232	4.332888813396239	TCIRG1;TNFRSF11A
Apoptosis Block by BCL2 Family Proteins in Cancer	2/40	0.18893364567227594	0.7173543046423755	0	0	2.600212652844232	4.332888813396239	BCL2L10;BCL2L11
TNFR -> CREB/ELK-SRF Signaling	2/40	0.18893364567227594	0.7173543046423755	0	0	2.600212652844232	4.332888813396239	MAPKAPK2;TNFRSF10B
Golgi to Endosome Transport	2/41	0.19617147200430263	0.7173543046423755	0	0	2.5334110334110336	4.12633412271929	PLIN3;RAB9A
Club-Cell Role in Asthma	2/41	0.19617147200430263	0.7173543046423755	0	0	2.5334110334110336	4.12633412271929	CEBPB;MAP3K14
Proteins Involved in Usher Syndromes	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	CIB2
Immunoglobulin Class-Switch Recombination via Alternative End-Joining	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	MDC1
Proteins Mutated in Cochlear Hair Cell Stereocilia	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	CIB2
RNase L Signaling in Prostate Cancer	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	GDF15
Prostaglandin E2 Receptor Signaling in Neurons	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	TNFRSF11A
Uric Acid Synthesis in Gout	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	ADA
Synaptic Potentiation by PKMZ in LTP Maintenance - Basal State	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	IQSEC1
Dihydrotestosterone Biosynthesis in Prostate Cancer	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	AKR1C4
EGF/cyclinD1 Signaling in Acquired Middle Ear Cholesteatoma	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	CDKN1A
EPHA2 Mutations in Cataract	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	CDH1
GABRB3 Mutation and Adenosine Deaminase Polymorphism	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	ADA
Hashimoto's Thyroiditis Triggers	1/11	0.19841376672453567	0.7173543046423755	0	0	4.935012594458438	7.981892813959033	TNFRSF10B
T-Cell Central Tolerance	2/42	0.20344305074784355	0.7173543046423755	0	0	2.469949494949495	3.933071407873571	BCL2L11;CBL
Clozapine Induced Granulocytopenia	2/42	0.20344305074784355	0.7173543046423755	0	0	2.469949494949495	3.933071407873571	CDKN1A;MAPKAPK2
STK11 Signaling in Pancreatic Neoplasms	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	STK11IP
Microtubule Cytoskeleton	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	TPPP
EctodysplasinR -> NF-kB Signaling	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	MAP3K14
TNFRSF5/13B -> NFATC1 Signaling	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	CBL
Glioblastoma, Classical Subtype	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	NES
Hyper IgM Syndrome	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	MAP3K14
nNOS (NOS1) and iNOS (NOS2) Activation via Glutamate	1/12	0.21437408837025337	0.7173543046423755	0	0	4.486146095717884	6.908811745265483	NOS1AP
CDH1 Down regulation Promotes Cancer Cell Migration and Metastases	2/44	0.21807083452018974	0.7173543046423755	0	0	2.352092352092352	3.582084565896582	CDH1;ZBTB33
HIF1A as Master Regulator of Angiogenesis in Cancer	2/44	0.21807083452018974	0.7173543046423755	0	0	2.352092352092352	3.582084565896582	P4HA2;RBX1
FOXO1 Signaling	2/44	0.21807083452018974	0.7173543046423755	0	0	2.352092352092352	3.582084565896582	BCL2L11;SH2B2
Proteins Involved in Glioma	8/290	0.22228302666604532	0.7173543046423755	0	0	1.4053464266230224	2.113365316636747	CDKN1A;DOCK4;CEBPB;ENTPD2;SPRY2;NOL3;NDRG1;NES
Prostate Cancer	4/123	0.22973932992537305	0.7173543046423755	0	0	1.662159279955637	2.444720425617928	CDKN1A;CDKN2B;BCL2L11;CLU
Progesterone Resistance in Endometriosis	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	BCL2L11
Proteins Involved in Marginal Zone Lymphoma	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CDKN1C
Proteins Involved in Werner Syndrome (Adult Progeria)	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	KAT5
Proteins with Altered Expression in Chronic Obstructive Pulmonary Disease	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CDKN1A
Ca2+ Cytosolic Overload	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	ATP8A1
Genes with Mutations in Cancer-Associated Histone Deacetylation	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	KAT5
TLR4 -> IRF Signaling	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CD14
TLR4/5/7/9 -> NF-kB Signaling	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CD14
Genes with Mutations Associated with Melanoma	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CDKN2B
Hyperhomocysteinemia Induced Thrombophilia	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CBS
MTHFR Mutation, Hyperhomocysteinemia and Folate Deficiency	1/13	0.23001740774880494	0.7173543046423755	0	0	4.1120906801007555	6.043129643887076	CBS
Oncogene Induced Cellular Senescence	2/46	0.23278523732640283	0.7173543046423755	0	0	2.244949494949495	3.2723258890107587	CDKN1A;SPRY2
TGFBR Signaling in Pancreatic Neoplasms	2/47	0.24016563054268952	0.7173543046423755	0	0	2.194949494949495	3.130934052023188	CDKN1A;CEBPB
BSG (CD147) in Cancer Cells Motility, Invasion and Survival	2/47	0.24016563054268952	0.7173543046423755	0	0	2.194949494949495	3.130934052023188	BCL2L11;SLC16A3
Proteins with Altered Expression in Cancer-Associated Resisting to Cell Death	2/47	0.24016563054268952	0.7173543046423755	0	0	2.194949494949495	3.130934052023188	BCL2L11;TNFRSF10B
AXL Receptor Tyrosine Kinase Signaling	2/47	0.24016563054268952	0.7173543046423755	0	0	2.194949494949495	3.130934052023188	MAPKAPK2;CBL
Osteoclast Activation in Psoriatic Arthritis	2/47	0.24016563054268952	0.7173543046423755	0	0	2.194949494949495	3.130934052023188	TNFRSF11A;CBL
Hormones Underlie Human Gastrointestinal Functions and Eating Behavior	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	CCK
Oxidative Stress in Amyotrophic Lateral Sclerosis	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	KEAP1
P2RXs -> Synaptic Transmission	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	SYT7
Glutamate Mediated Neurotoxicity	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	CEBPB
NGFR -> NF-kB Signaling	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	MAP3K14
Crystallin alpha B (CRYAB) Suppresses Multiple Sclerosis	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	MAP3K14
Glutamate, D-Serine, and ATP Release from Astrocytes	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	SYT7
Microglia Activation in Alzheimer's Disease	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	CD14
NOTCH Signaling in Multiple Myeloma	1/14	0.24535000550509134	0.7173543046423755	0	0	3.795582251501647	5.333056833585132	CDKN1A
Proteins Involved in Retinitis Pigmentosa	4/127	0.24689887075594696	0.7173543046423755	0	0	1.6077751640460567	2.248918046542027	CBS;UNC119;MERTK;SLC19A2
Negative Acute Phase Proteins Synthesis	2/48	0.24755680695819757	0.7173543046423755	0	0	2.1471234079929733	2.9976316267037486	SERPINA6;MAP3K14
T-Cell Cytotoxic Mediated Cell Death	2/48	0.24755680695819757	0.7173543046423755	0	0	2.1471234079929733	2.9976316267037486	CRADD;TNFRSF10B
mTOR/NF-kB/BCR Signaling Disregulation in Mantle Cell Lymphoma	2/49	0.2549554239750257	0.7173543046423755	0	0	2.1013324736728993	2.8718208170023938	BCL2L11;MAP3K14
ADORA1/2A -> Exocytosis	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	SYT7
PTPRN/STAT5 in Insulin Synthesis in beta-Cell (Rodent Model)	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	SH2B2
DNA Replication in DNA Machinery	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	KAT7
IL13/STAT6/ZEB1 Signalling Promotes Cancer Metastatic Progression	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	CDH1
Proteins with Altered Expression in Cancer-Associated Histone Deacetylation	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	KAT5
Adipose Tissue Inflammation Provokes Insulin Resistance	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	MAP3K14
Berardinelli-Seip Syndrome Progression (Hypothesis)	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	AGPAT2
Cathepsins Role in Periodontitis	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	CD14
Desmosomes Role in Dilated Cardiomyopathy	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	CDH1
Familial Partial Lipodystrophy Type 2 Progression (Hypothesis)	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	AGPAT2
Glutamate Mediated Excitotoxicity in Amyotrophic Lateral Sclerosis	1/15	0.26037803815842425	0.7173543046423755	0	0	3.524289312702411	4.742356690988355	CEBPB
Natural Killer Cell Inhibitory Receptor Signaling	2/51	0.2697622462429609	0.7173543046423755	0	0	2.015357658214801	2.6405503778268513	CBL;BAIAP2
Apoptosis Block by Death Receptor Signaling in Cancer	2/51	0.2697622462429609	0.7173543046423755	0	0	2.015357658214801	2.6405503778268513	CRADD;TNFRSF10B
Inflammatory Reaction in Acne Vulgaris	2/51	0.2697622462429609	0.7173543046423755	0	0	2.015357658214801	2.6405503778268513	TXNIP;MAP3K14
Diffuse Large-B-Cell Lymphoma	3/91	0.27164705463577055	0.7173543046423755	0	0	1.6841772151898735	2.1949067321298585	CDKN2B;TNFRSF11A;MAP3K14
Frizzled Receptors -> ARRB1/ARRB2 Canonical Signaling	1/16	0.27510754055879844	0.7173543046423755	0	0	3.289168765743073	4.244978846604293	BTRC
Muscular Dystrophy, Facioscapulohumeral	1/16	0.27510754055879844	0.7173543046423755	0	0	3.289168765743073	4.244978846604293	CDKN1A
Neurofibrillary Tangle Formation	1/16	0.27510754055879844	0.7173543046423755	0	0	3.289168765743073	4.244978846604293	TNFRSF10B
Myeloid Derived Suppressor Cells in Cancer Immune Escape	2/52	0.2771643919709183	0.7173543046423755	0	0	1.974949494949495	2.534145534845056	CCND3;KEAP1
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes	2/53	0.2845618521010458	0.7173543046423755	0	0	1.9361259655377303	2.433332102367948	CDKN1A;MAPKAPK2
Proteins Involved in Pancreatic Cancer	3/94	0.28789019039483577	0.7173543046423755	0	0	1.6284045068855195	2.027650462512763	CDKN1A;CDH1;KLF4
Proteins Involved in Follicular Lymphoma	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	CCND3
PTGIR -> IL6 Production	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	MAPKAPK2
Vitamin C Related Norepinephrine Synthesis	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	SLC23A2
Ethanol Induced Hepatotoxicity	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	CEBPB
Apoptosis of Mantle Cell Deregulation	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	BCL2L11
Cochlear Hair Cell Stereocilia Proteins Mutations (Age-Related)	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	CIB2
SELE -> ELK-SRF Signaling	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	MAPKAPK2
Familial Partial Lipodystrophy Type 4 Progression (Hypothesis)	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	AGPAT2
Microglia Activation in Parkinson's Disease	1/17	0.28954442831900873	0.7173543046423755	0	0	3.0834382871536525	3.8217568794618937	CD14
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway	2/55	0.2993318715208778	0.7173543046423755	0	0	1.8628740232513818	2.247003085926541	CDKN1A;CCNE1
Epigenetic Alterations Triggers Genomic Instability	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	SLC46A1
HTR7 -> IL6 Production	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	MAPKAPK2
Toll-like Receptors in Pyelonephritis	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	CD14
Desmosome Assembly	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	CDH1
Monoblast -> Promonocyte Surface Expression Markers	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	CD14
TGFBR -> CREB/ELK-SRF Signaling	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	MAPKAPK2
FOXA2 Signaling in Prostate Cancer	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	GDF15
FOXL2 Mutation in Ovarian Dysgenesis	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	IER3
IL6/IL12 Signaling Activates Immune System in Multiple Sclerosis	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	CEBPB
Oxidative Stress, All-Trans-Retinal and Lipofuscin Toxicity in AMD	1/18	0.3036945000802164	0.7173543046423755	0	0	2.901911394280634	3.458303620413356	KEAP1
Proteins Involved in Polycystic Kidney Disease	3/97	0.3042049461673368	0.7173543046423755	0	0	1.5761917586856988	1.8757527392873845	CDKN1A;CEBPB;BCL2L11
Proteins Involved in B-Cell Chronic Lymphocytic Leukemia	2/56	0.3066992813240795	0.7173543046423755	0	0	1.8282828282828283	2.1608247146710355	CD52;CDKN1A
T-Cell Independent B-Cell Activation	2/56	0.3066992813240795	0.7173543046423755	0	0	1.8282828282828283	2.1608247146710355	CD14;MAP3K14
Proteins Involved in Parkinson's Disease	3/98	0.3096533849597957	0.7173543046423755	0	0	1.5595203197868088	1.8282283534022823	CD14;ADA;RNF41
Prolactinoma Overiew	2/57	0.31405170009913075	0.7173543046423755	0	0	1.7949494949494949	2.0789062988196623	CCNB2;CDKN1A
beta-Cell Destruction through Cytokines in Diabetes Mellitus	2/57	0.31405170009913075	0.7173543046423755	0	0	1.7949494949494949	2.0789062988196623	CEBPB;MAP3K14
HPV E6 and E7 Induced Disruption of TNFR/NF-kB Signaling in Keratinocytes	2/57	0.31405170009913075	0.7173543046423755	0	0	1.7949494949494949	2.0789062988196623	BTRC;RBX1
MITF as a Regulator of Melanoma Cell Development	2/57	0.31405170009913075	0.7173543046423755	0	0	1.7949494949494949	2.0789062988196623	CDKN1A;CDH1
DRD1/5 Expression Targets	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	MAPKAPK2
Macrophage Related Iron Uptake and Release	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	CEBPB
ER Associated Protein Degradation in Vesicular Transport	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	HERPUD1
Hedgehog Signaling Activation by Blocking of Tumor Suppressors	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	CCNB1
Hedgehog Signaling Activation in Cancer	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	CCNB1
Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	CEBPB
Androgen Receptor Genomic Signaling	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	KAT7
Apoptosis of Myocyte	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	TNFRSF10B
Corneodesmosomes in Atopic Dermatitis	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	CDH1
Genes with Mutations Associated with Psoriasis	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	MICA
Glutamate Overdose and Aura Effect in Familial Hemiplegic Migraine Type 3	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	SYT7
Glutamate Overdose and Aura Effect in Migraine Type 2	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	SYT7
Leptin in Insulin Synthesis and Secretion	1/19	0.3175634399468436	0.7173543046423755	0	0	2.7405541561712847	3.143628475292091	SH2B2
Effector T-cell Inactivation in Cancer Immune Escape	2/58	0.3213868110548861	0.7173543046423755	0	0	1.7628066378066378	2.000979200152619	TNFRSF10B;EBAG9
Myoblast -> Neutrophil Surface Expression Markers	2/58	0.3213868110548861	0.7173543046423755	0	0	1.7628066378066378	2.000979200152619	CD52;CD14
Proteins Involved in Psoriatic Arthritis	2/59	0.3287023952153521	0.7173543046423755	0	0	1.7317916002126528	1.9267956836250668	TNFRSF11A;MICA
Positive Acute Phase Proteins Synthesis	2/59	0.3287023952153521	0.7173543046423755	0	0	1.7317916002126528	1.9267956836250668	CEBPB;MAPKAPK2
Antigen-Presenting Cell Role in Asthma	2/59	0.3287023952153521	0.7173543046423755	0	0	1.7317916002126528	1.9267956836250668	CD14;IFI30
Bone Remodeling in Hyperthyroidism	2/59	0.3287023952153521	0.7173543046423755	0	0	1.7317916002126528	1.9267956836250668	TNFRSF11A;MAP3K14
HTR5 -> TNF Production	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	MAPKAPK2
P2RY11/13/14 -> IL8/10 Production	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	MAPKAPK2
Vascular Smooth Muscle Cell/Pericyte Differentiation and Proliferation	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	KLF4
Double Strand DNA Homologous Repair	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	MDC1
Histone Acetylation	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	KAT5
MicroRNAs in Epithelial to Mesenchymal Transition in Cancer	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	CDH1
alpha-Cell to beta-Cell Interconversion (Hypothesis)	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	MAFB
IL2R -> ELK/SRF/MYC Signaling	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	MAPKAPK2
Genes with Mutations Associated with Asthma	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	CD14
Myostatin in Skeletal Muscles in Muscular Dystrophies	1/20	0.3311568194820695	0.7173543046423755	0	0	2.596181890494498	2.869204792144366	FSTL3
T-Cell Acute Lymphoblastic Leukemia	3/103	0.336919677176804	0.7173543046423755	0	0	1.4811645569620253	1.6113748050762697	CCND3;CDKN1A;CDKN2B
Proteins Involved in Male Infertility	5/193	0.3395806396825937	0.7173543046423755	0	0	1.313816252503925	1.4189791442990716	CDKN2D;ATP8A1;BTRC;FSTL3;CLGN
Medulloblastoma	3/104	0.34237000296284037	0.7173543046423755	0	0	1.466424363955383	1.5718063798209392	CCNA2;CDKN1A;CCNE1
Proteins Involved in Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	PPP1R13L
Sonic Hedgehog Signaling in Neuroblastoma	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	CCNB1
Dexamethasone Induced Osteoporosis	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	TNFRSF11A
IGF1R -> ELK/SRF/HIF1A/MYC/SREBF Signaling	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	MAPKAPK2
CCL2 Role in CGRP Expression and Release	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	SYT7
InsulinR -> ELK/SRF/SREBF Signaling	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	MAPKAPK2
Conventional Dendritic Cell Role in Diabetes Mellitus Type 1	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	TXNIP
FSH Action in Polycystic Ovary Syndrome	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	MAPKAPK2
Glutamate Overdose and Aura Effect in Migraine Type 1	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	SYT7
IFN-gamma/TNF-alpha Mediated Cell Proliferation in Psoriasis	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	KLF4
IL17F Signaling in Bronchial Epithelial Cell in Asthma	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	MAPKAPK2
MEN1 Mutation in Hyperparathyroidism	1/21	0.34448010029721693	0.7173543046423755	0	0	2.4662468513853906	2.6283260152839016	CDKN1A
Proteins Involved in Celiac Disease	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MICA
Proteins with Altered Expression in Aging	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	SPRY2
TNFR/NF-kB Alternative Pathway in Multiple Myeloma Plasma Cells	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MAP3K14
Doxorubicin Induced Cardiotoxicity	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MAPKAPK2
G1/S Damage Checkpoint	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	CDKN1A
CD19 -> JUN/ELK Signaling	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MAPKAPK2
Apoptosis of Chondrocyte	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MAP3K14
IL4R -> ELK/SRF/HMGY Signaling	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MAPKAPK2
EGFR Nuclear Signaling in Colorectal Cancer	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	MDC1
Epithelial Cell in the Innate Immune Response in Ulcerative Colitis	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	CDH1
HPV E6 and E7 Induced Block of Apoptosis in Keratinocytes	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	CDKN1A
Lymphoma, GCB Subtype	1/22	0.35753863601625663	0.7173543046423755	0	0	2.3486865779057213	2.415651977111805	CDKN2B
Natural Killer Cell Activation through ITAM-Containing Receptors	2/63	0.3577283383684201	0.7173543046423755	0	0	1.6179003146216262	1.6631714499207342	CBL;BAIAP2
Dendritic Cell Dysfunction in Psoriatic Arthritis	2/63	0.3577283383684201	0.7173543046423755	0	0	1.6179003146216262	1.6631714499207342	TXNIP;CD14
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway	2/64	0.364916219146656	0.7173543046423755	0	0	1.591723688497882	1.6045967352559043	CDKN1A;CCNE1
AHR Signaling in M1 Macrophages Function	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	CD14
Proteins with Altered Expression in Endometrial Cancer	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	CDH1
NPY1R -> CRH/POMC Production	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	MAPKAPK2
APC/C-FZR1 Complex	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	CCNB1
TERT/WNT Activation in Cancer	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	KLF4
ActivinR -> SMAD2/3 Signaling	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	GDF11
Aqueous Humor Production	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	SLC23A2
beta-Catenin/Androgen Receptor Signaling in Prostate Cancer	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	CDH1
ICAM1 -> AP-1/CREB/ELK/SRF Signaling	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	MAPKAPK2
UrokinaseR -> ELK/SRF Signaling	1/23	0.37033767418953517	0.7173543046423755	0	0	2.2418136020151134	2.2268832503020737	MAPKAPK2
Androgens in Sebocyte Maturation	2/65	0.37207315003870184	0.7173543046423755	0	0	1.5663780663780664	1.5486228642222433	CEBPB;DGAT1
Proteins Involved in Inflammatory Bowel Diseases	2/66	0.3791975172624705	0.7173543046423755	0	0	1.541824494949495	1.4951042153320988	VNN1;REEP6
Proteins Involved in Fragile X Syndrome	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	FXR2
CRH Secretion Regulation	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	MAPKAPK2
Synaptic Exocytosis in Dementia	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	SNPH
Synaptic Potentiation by PKMZ in LTP Maintenance - Active State	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	IQSEC1
WNT Signaling in Melanoma	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	CDH1
Lactate as a Signaling Molecule in Cancer Cells	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	SLC16A3
Mutations in Krebs Cycle Enzymes in Cancer	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	KEAP1
TRRAP/TIP60 in Chromatin Remodeling	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	KAT5
Amyloid beta Traffic and Degradation in Extracellular Matrix in Alzheimer's Disease	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	CLU
Antiphospholipid Antibodies and Endothelial Cell Interaction	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	MAP3K14
Antiphospholipid Antibodies in Endothelial Cell	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	MAP3K14
TLR -> AP-1 Signaling	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	CD14
G-Proteins Signaling in Insulin Secretion in beta-Cell	1/24	0.3828823589195501	0.7173543046423755	0	0	2.1442339283758622	2.058523524490763	CCK
CD16/CD14 Proinflammatory Monocyte Activation	2/67	0.38628778327705066	0.7195989562761057	0	0	1.518026418026418	1.4439051876881668	CD14;CBL
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis	2/67	0.38628778327705066	0.7195989562761057	0	0	1.518026418026418	1.4439051876881668	CCNB1;CDH1
Hypoxia Inhibits mTOR Signaling	1/25	0.3951777323518421	0.720400520593882	0	0	2.054785894206549	1.9077036211886893	STK11IP
MHC1 Causes Antigen Presentation Failure in Cancer Immune Escape	1/25	0.3951777323518421	0.720400520593882	0	0	2.054785894206549	1.9077036211886893	MICA
Familial Mediterranean Fever	1/25	0.3951777323518421	0.720400520593882	0	0	2.054785894206549	1.9077036211886893	TXNIP
Local Estrogen Production in Endometriosis	1/25	0.3951777323518421	0.720400520593882	0	0	2.054785894206549	1.9077036211886893	CEBPB
Osteoclast Activation in Multiple Myeloma	2/69	0.40036022748155625	0.720400520593882	0	0	1.4725614352480023	1.347968849272964	TNFRSF11A;MAP3K14
Kidney Cells Cilia Organization	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	CDH1
Sarcomere in Cardiomyocyte in Dilated Cardiomyopathy	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	TCAP
mRNA Degradation	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	PAN2
APP and Glutamate Signaling Cause Neuronal Dysfunction in Alzheimer Disease	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	CEBPB
Cryopyrin (NLPR3) Associated Periodic Syndromes	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	TXNIP
GUCY2C Signaling in Colorectal Cancer	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	CDX2
PAPA Syndrome	1/26	0.40722873706880214	0.720400520593882	0	0	1.972493702770781	1.772049373720507	TXNIP
Dilated Cardiomyopathy	2/70	0.4073396901004213	0.720400520593882	0	0	1.4508318478906714	1.303003431329993	TCAP;MAP3K14
Proteins with Altered Expression in Psoriasis	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	KLF4
Reperfusion Injury in Myocardial ischemia	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	BCL2L11
NTSR1 Expression Targets	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	MAPKAPK2
Cancer Cells Inhibit Adipocyte Differentiation	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	MAP3K14
Aldosterone Synthesis Acute Regulation	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	MAPKAPK2
ActivinR/BMPR -> SMAD1/5/9 Signaling	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	GDF11
FcIgER -> ELK-SRF Signaling	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	MAPKAPK2
Ca2+ Toxicity in Neurons	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	KAT5
MIF Role in Cholesteatoma	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	CBL
Oxidation of Fatty Acid in non-Alcoholic Fatty Liver Disease	1/27	0.4190402179098048	0.720400520593882	0	0	1.8965316799069947	1.6495812140738464	CEBPB
Glioma Stem Cell Program Activation	2/72	0.42117881308457206	0.720400520593882	0	0	1.4092352092352092	1.2185625869488979	KLF4;NES
Proteins Involved in Hypogonadotropic Hypogonadism	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	HS6ST1
I-cell: CCK-8 Secretion and Regulation of Eating Behavior	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	CCK
Proteins with Altered Expression in Prostate Cancer	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	CDH1
Histone Methylation	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	ZBTB33
BMP/TGF-beta Signaling Impairment in Pulmonary Hypertension	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	CDKN2B
TNFRSF1A -> AP-1/ATF/TP53 Signaling	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	MAP3K14
Familial Cold Autoinflammatory Syndrome 2	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	TXNIP
Hyperglycemia and Hyperlipidemia Trigger beta-Cell Apoptosis	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	CEBPB
Il17 Signaling Related Neutrophilia in Asthma	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	MAPKAPK2
Postsynaptic Neuron Activation	1/28	0.43061692371314897	0.720400520593882	0	0	1.8261964735516374	1.5386369882611264	NOS1AP
Metastatic Colorectal Cancer	3/121	0.43373030541558855	0.720400520593882	0	0	1.2540656511478223	1.0475616126117124	CDKN1A;CDX2;CDH1
TAM Receptor Signaling Activation in Cancer	2/74	0.434850569479546	0.720400520593882	0	0	1.369949494949495	1.1408293125022337	CDH1;MERTK
CXC Chemokine Receptor Signaling	2/75	0.44162105185722195	0.720400520593882	0	0	1.3511138785111387	1.1042695794345478	RASGRP2;MAP3K14
AHR Signaling in Tr1 Cells Function	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MAP3K14
CHRM1 -> IL2 Production	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MAPKAPK2
Complement Activation in Macular Degeneration	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	CLU
Eat me Signal: Apoptotic Cell Induces Phagocytosis	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MERTK
HTR1 -> IL6 Production	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MAPKAPK2
Immunoglobulin Class-Switch Recombination Activation	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MAP3K14
SPP1 Induced Survival of Myelin Specific T-Cells in Multiple Sclerosis	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	BCL2L11
Toll-like Receptors (TLR) in Periodontitis	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	CD14
Lamellipodia and Filopodia Formation in Cancer	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	BAIAP2
NOTCH Signaling Deregulation in Cancer	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	CDKN1A
NOTCH Receptors Signaling	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	CDKN1A
TNFRSF1A -> CREB/ELK-SRF Signaling	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	MAPKAPK2
IL6 Promotes Inflammation in Muscular Dystrophies	1/29	0.4419635095667988	0.720400520593882	0	0	1.7608852105073767	1.437812004950335	CEBPB
ADRA1A -> IL6 Production	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	MAPKAPK2
Proteins Involved in Cystic Kidney Disease	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	SPRY2
Male Sex Determination	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	VNN1
Sarcomere Disorganization and Intracellular Calcium Overload	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	TCAP
TNFR/NF-kB Classical Pathway in Multiple Myeloma Plasma Cells	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	MAP3K14
Intraflagellar Transport: BBSome Interaction	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	RAB11FIP3
Persistent Double Strand DNA Homologous Repair in Cancer	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	MDC1
BMPR2 Signaling	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	CEBPB
WNT Canonical Signaling	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	BTRC
Mast-Cell Related Chemokines Signaling in Asthma	1/30	0.4530845386007315	0.7205149247992121	0	0	1.7000781725006515	1.3459120248562908	BAIAP2
Natural Killer Cell Precursor -> Natural Killer Cell Surface Expression Markers	2/78	0.46165965097134076	0.7272064499387413	0	0	1.2975810738968634	1.0029358951430272	ENTPD2;MICA
Macrophage M2-Related Phagocytosis	1/31	0.4639844833964975	0.7272064499387413	0	0	1.6433249370277079	1.2619160689670375	CD14
Vascular Endothelial Cell Activation by NO	1/31	0.4639844833964975	0.7272064499387413	0	0	1.6433249370277079	1.2619160689670375	S1PR2
ER Stress (Unfolded Protein Response)	1/31	0.4639844833964975	0.7272064499387413	0	0	1.6433249370277079	1.2619160689670375	CEBPB
B-Cell Mediated IgE Production in Asthma	1/31	0.4639844833964975	0.7272064499387413	0	0	1.6433249370277079	1.2619160689670375	MAP3K14
GNRH Signaling Impairment in Hypogonadotrophic Hypogonadism	1/31	0.4639844833964975	0.7272064499387413	0	0	1.6433249370277079	1.2619160689670375	MAPKAPK2
Th0-Cell Aberrant Activation in Systemic Lupus Erythematosus	2/79	0.4682454205552429	0.729913582139424	0	0	1.2806637806637806	0.971719930573723	TNFRSF10B;MAP3K14
Apoptosis Block in Infected Cells	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	MAP3K14
T-Cell Receptor -> ATF/CREB Signaling	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	MAPKAPK2
FOXO1 and SREBP-1C Role in beta-Cell Suppression (Rodent Model)	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	SH2B2
Glutamate Toxiicity Effects on Striatum Medium Spiny Neurons in Hantington's Disease	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	CEBPB
Lipid Metabolism Impairement in non-Alcoholic Fatty Liver Disease	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	DGAT1
Myostatin-IGF1 Crosstalk in Skeletal Muscles in Muscular Dystrophies	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	CDKN1A
Ovulation Block	1/32	0.4746677282624475	0.729913582139424	0	0	1.5902332006175348	1.1849467474487747	MAPKAPK2
Proteins Involved in Insulin Resistance	2/81	0.48127178291950545	0.7338987196076764	0	0	1.2481140519115204	0.9127746765325732	CEBPB;DGAT1
mTOR Signaling	2/81	0.48127178291950545	0.7338987196076764	0	0	1.2481140519115204	0.9127746765325732	BTRC;RBX1
Hypothalamic-Pituitary-Adrenal Axis in Acute Phase Response	1/33	0.485138570783602	0.7338987196076764	0	0	1.5404596977329974	1.1142464113746267	MRAP2
Persisted DNA Repair Triggers Genomic Instability	1/33	0.485138570783602	0.7338987196076764	0	0	1.5404596977329974	1.1142464113746267	MDC1
Alcoholic Dilated Cardiomyopathy (Mouse Model)	1/33	0.485138570783602	0.7338987196076764	0	0	1.5404596977329974	1.1142464113746267	TCAP
Ras Signaling	1/33	0.485138570783602	0.7338987196076764	0	0	1.5404596977329974	1.1142464113746267	RALGPS1
IGF1 Role in Muscle Hypertrophy	1/33	0.485138570783602	0.7338987196076764	0	0	1.5404596977329974	1.1142464113746267	CDKN1A
Proteins Involved in Amyotrophic Lateral Sclerosis	4/181	0.48703854599612195	0.7350674351608137	0	0	1.1141701798158823	0.8015474075878563	BCL2L11;KEAP1;CCK;ADARB1
TSLP Signaling in Bronchial Epithelial Cell in Asthma	1/34	0.4954012233299817	0.7425324083014898	0	0	1.4937027707808563	1.0491578450457135	CDKN1A
Diabetes Induced Periodontitis	1/34	0.4954012233299817	0.7425324083014898	0	0	1.4937027707808563	1.0491578450457135	MAP3K14
OipA Signaling in Helicobacter Pylori Infection	1/34	0.4954012233299817	0.7425324083014898	0	0	1.4937027707808563	1.0491578450457135	CDH1
Natural Killer Cell Activation through C-Type Lectin-like Receptors	1/35	0.5054598152801061	0.7489995444605209	0	0	1.4496962512964884	0.9891085273684115	MICA
Thyroid Stimulating Hormone (TSH) Secretion in Overt Hypothyroidism	1/35	0.5054598152801061	0.7489995444605209	0	0	1.4496962512964884	0.9891085273684115	CCK
TLR2 Induced Synovial Fibroblast Activation in Rheumatoid Arthritis	1/35	0.5054598152801061	0.7489995444605209	0	0	1.4496962512964884	0.9891085273684115	CD14
Huntingtin Gene Mutation in Striatal Neuron	1/35	0.5054598152801061	0.7489995444605209	0	0	1.4496962512964884	0.9891085273684115	TCERG1
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death	1/35	0.5054598152801061	0.7489995444605209	0	0	1.4496962512964884	0.9891085273684115	MAP3K14
Thymic Follicular Hyperplasia	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	MAP3K14
WNT Signaling Activation by Blocking of Tumor Suppressors	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	CDH1
Lysophosphatidic Acid/LPARs Signaling	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	LPAR6
Cochlear Hair Cell Stereocilia Proteins Mutations (Congenital Deafness)	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	CIB2
PI3K/RAC1 Signaling	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	BAIAP2
Estrogen Effects on Pregnancy Gingivitis	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	CDH1
Neutrophil Recruitment in Sinovium in Gout	1/36	0.5153183939262411	0.7516500958387231	0	0	1.4082043900683698	0.9335977273842534	MAP3K14
Eosinophil Activation	2/87	0.5191451346895781	0.7527034464513	0	0	1.159655377302436	0.7602373537563945	CEBPB;MAP3K14
Proteins Involved in Cholesteatoma	1/37	0.5249809267815659	0.7527034464513	0	0	1.3690176322418135	0.8821858541290871	TNFRSF11A
Lipolysis Regulation in Adipocyte	1/37	0.5249809267815659	0.7527034464513	0	0	1.3690176322418135	0.8821858541290871	MAP3K14
TNF Receptor Associated Periodic Syndrome	1/37	0.5249809267815659	0.7527034464513	0	0	1.3690176322418135	0.8821858541290871	MAP3K14
VEGFR -> ATF/CREB/ELK-SRF Signaling	1/37	0.5249809267815659	0.7527034464513	0	0	1.3690176322418135	0.8821858541290871	MAPKAPK2
Plasmacytoid Dendritic Cell in Diabetes Mellitus Type 1	1/37	0.5249809267815659	0.7527034464513	0	0	1.3690176322418135	0.8821858541290871	TXNIP
CC Chemokine Receptor Signaling	2/88	0.5252761781216895	0.7527034464513	0	0	1.1461122856471693	0.7379027349018075	RASGRP2;MAP3K14
Proteins Involved in HIV Type 1 Infection	2/88	0.5252761781216895	0.7527034464513	0	0	1.1461122856471693	0.7379027349018075	CEBPB;CD14
Hypertrophic Cardiomyopathy	2/89	0.5313543605379834	0.755883404199211	0	0	1.1328805294322535	0.7163499662192148	TCAP;MAP3K14
Mineralcorticoids Secretion Regulation	1/38	0.5344513026623255	0.755883404199211	0	0	1.331949077541017	0.8344856246204767	MAPKAPK2
TNF and IL1B Induce Metalloproteinase Synthesis in Osteoarthritis	1/38	0.5344513026623255	0.755883404199211	0	0	1.331949077541017	0.8344856246204767	MAP3K14
Blau Syndrome	1/38	0.5344513026623255	0.755883404199211	0	0	1.331949077541017	0.8344856246204767	SUGT1
HGFR -> AP-1/CREB/MYC Signaling	1/38	0.5344513026623255	0.755883404199211	0	0	1.331949077541017	0.8344856246204767	MAPKAPK2
Dedifferentiation and Metastatic Progression in Melanoma	1/38	0.5344513026623255	0.755883404199211	0	0	1.331949077541017	0.8344856246204767	CDH1
CNR1/2 -> IL1B/2/4/6/10 Production	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	MAPKAPK2
DRD2 Expression Targets	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	MAPKAPK2
Inhibition of THBS1 Activates Angiogenesis in Cancer	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	TNFRSF10B
Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	PTGES3
Apoptosis Block in Melanoma Cell	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	BCL2L11
Hair Follicle Keratinocyte Apoptosis	1/39	0.543733333611653	0.7591309068839353	0	0	1.2968314994034205	0.7901546963998277	BCL2L11
Proteins Involved in Azoospermia	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	EIF1AY
EDNRA/B -> Vascular Motility	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	MAPKAPK2
Proteins Involved in T-Cell Acute Lymphoblastic Leukemia	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	CCND3
SIRT1 Signaling in Aging	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	CDKN1A
Telomer Attrition Triggers Genomic Instability	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	CDKN1A
Glycolysis Activation in Cancer (Warburg Effect)	1/40	0.5528307560486267	0.7620415495638576	0	0	1.2635148227087774	0.7488894950186479	TXNIP
Proteins Involved in Spontaneous Abortion	2/93	0.555132411754835	0.7630399909831093	0	0	1.0828615828615828	0.6373166836960075	CDH3;CDH1
AXL Receptor Inhibits Macrophages and Dendritic Cells Function	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	CD14
Proteins with Altered Expression in Endometriosis	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	CDH1
AMPK Signaling	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	STK11IP
Astrocytoma	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	CDKN1A
T-Cell Receptor -> NF-kB Signaling	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	MAP3K14
Mesangial Cell Dysfunction in Glomerulonephritis	1/41	0.5617472326256019	0.7630399909831093	0	0	1.2318639798488664	0.7104200152763227	MAPKAPK2
Proteins Involved in Atherosclerosis	4/200	0.5655041349939984	0.7665461455635905	0	0	1.0051797368693671	0.5729903164933543	AOC3;LIPG;ESAM;MERTK
Hippo/YAP1 Signaling Deregulation in Cancer	1/42	0.5704863534075238	0.7675654111723677	0	0	1.2017570805430977	0.6745054260697908	CBL
Skeletal Muscle Wasting in Cancer Cachexia	1/42	0.5704863534075238	0.7675654111723677	0	0	1.2017570805430977	0.6745054260697908	MAP3K14
Proteins Involved in Mucinous Ovarian Carcinoma	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	CCNE1
WNT Signaling in Cystic Kidney Disease	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	BTRC
WNT in Epithelial to Mesenchymal Transition in Cancer	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	CDH1
Dendritic Cell Dysfunction in Crohn's disease	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	CD14
VEGFR -> AP-1/CREB/MYC Signaling	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	MAPKAPK2
Graves Ophthalmopathy	1/43	0.5790516373644252	0.7675654111723677	0	0	1.173083843109032	0.6409303370578088	CEBPB
Proteins Involved in Huntington Disease	2/98	0.5836356959637303	0.7675654111723677	0	0	1.026199494949495	0.5525861585618109	TCERG1;TRIP10
MC1R in anti-Inflammatory Signaling	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	CD14
Adipokines Production by Adipocyte Impaired in Obesity	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	MAP3K14
Adiponectin Synthesis Declines in Insulin Resistance	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	CEBPB
Treg Cells Promote Immunosuppression in Cancer Immune Escape	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	MAP3K14
Alveolar Macrophage Negative Regulation Declined in COPD	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	CD14
beta-Cell Mass Regulation	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	SH2B2
CagA Phosphorylation Independent Signaling	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	CDH1
Ras-GRF Regulation Signaling	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	RASGRP2
Eosinophil Activation and Degranulation in Asthma	1/44	0.5874465340107538	0.7675654111723677	0	0	1.145744244625388	0.6095016151310778	CEBPB
Proteins Involved in Presbycusis	1/45	0.595674424315643	0.7677039293536684	0	0	1.119647355163728	0.5800456610477267	TXNIP
Splenic Marginal Zone Lymphoma	1/45	0.595674424315643	0.7677039293536684	0	0	1.119647355163728	0.5800456610477267	MAP3K14
Hemapoietic Stem Cell -> Lymphoid Multipotent Progenitor Surface Expression Markers	1/45	0.595674424315643	0.7677039293536684	0	0	1.119647355163728	0.5800456610477267	CD14
CagA Phosphorylation Dependent Signaling	1/45	0.595674424315643	0.7677039293536684	0	0	1.119647355163728	0.5800456610477267	MAPKAPK2
Proteins Involved in Hearing Loss	4/209	0.6002939837691661	0.7677039293536684	0	0	0.9606041847220502	0.4902306770581752	CDKN2D;PNPT1;CIB2;SLC19A2
Adipokines Production by Adipocyte	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	MAP3K14
Proteins Involved in Clear Cell Ovarian Carcinoma	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	CCNE1
Proteins with Altered Expression in Melanoma	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	CDH1
Subepithelial Fibroblasts in Middle Ear Cholesteatoma	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	MAP3K14
Toll-like Receptors in beta-Cell	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	MAP3K14
Apoptotic Keratinocytes Clearance Recession in Systemic Lupus Erythematosus	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	TXNIP
MERTK Signaling	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	MERTK
Ras-GAP Regulation Signaling	1/46	0.6037386225594563	0.7677039293536684	0	0	1.0947103274559193	0.5524060683047124	RASA4
IL1B Expression Targets -> Nociception	1/47	0.6116423772264105	0.7677039293536684	0	0	1.0708575183441025	0.5264416069460216	CEBPB
Genes with Mutations in Cancer-Associated Evading of Growth Suppressors	1/47	0.6116423772264105	0.7677039293536684	0	0	1.0708575183441025	0.5264416069460216	CDH1
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling	1/47	0.6116423772264105	0.7677039293536684	0	0	1.0708575183441025	0.5264416069460216	MAPKAPK2
Growth Factor Signaling in Neuroblastoma	1/47	0.6116423772264105	0.7677039293536684	0	0	1.0708575183441025	0.5264416069460216	MAP3K14
Proteins Involved in Endometrioid Ovarian Carcinoma	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	CCNE1
Proteins Involved in Low-Grade Serous Ovarian Carcinoma	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	CCNE1
T-Cell Cytotoxic Response in Ulcerative Colitis	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	MAP3K14
Vascular Smooth Muscle Cell/Pericyte Migration and Proliferation	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	MAPKAPK2
Proteins with Altered Expression in Cancer Immune Escape	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	MICA
Diffuse Large-B-Cell Lymphoma ABC Subtype	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	CDKN2B
Glioblastoma, Primary	1/48	0.6193888726438028	0.7677039293536684	0	0	1.04801972238598	0.5020244786588842	CDKN1A
Proteins Involved in Obesity	2/106	0.6263955772329548	0.7677039293536684	0	0	0.9468725718725719	0.44292160814775544	CDKN1A;CCK
Proteins with Altered Expression in Cancer Metastases	2/106	0.6263955772329548	0.7677039293536684	0	0	0.9468725718725719	0.44292160814775544	BCL2L11;CDH1
Proerythroblast -> Erythrocyte Surface Expression Markers	1/49	0.6269812300033483	0.7677039293536684	0	0	1.026133501259446	0.4790388040970891	ENTPD2
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling	1/49	0.6269812300033483	0.7677039293536684	0	0	1.026133501259446	0.4790388040970891	MAPKAPK2
Cardiomyocyte Dysfunction	1/49	0.6269812300033483	0.7677039293536684	0	0	1.026133501259446	0.4790388040970891	TCAP
Goblet-Cell Related Mucus Secretion in Asthma	1/49	0.6269812300033483	0.7677039293536684	0	0	1.026133501259446	0.4790388040970891	MAP3K14
Mesangial Cell Dysfunction in Diabetic Nephropathy	1/49	0.6269812300033483	0.7677039293536684	0	0	1.026133501259446	0.4790388040970891	MAPKAPK2
Cortisol in Resolving Inflammation	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	PTGES3
Proteins Involved in Hodgkin Lymphoma	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	CCNB1
Proteins Involved in Vitiligo	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	GDF15
Neutrophil Activation via FCGR3B	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	BAIAP2
Synovial Fibroblast Activation in Psoriatic Arthritis	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	MAP3K14
Eosinophil Survival in Asthma	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	MAP3K14
Glioblastoma, Secondary	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	CDKN1A
Natural Killer Cell in Diabetes Mellitus Type 1	1/50	0.6344225087927318	0.7677039293536684	0	0	1.0051405952809336	0.45737930598739296	CBL
Breast Cancer	2/108	0.6365392842388893	0.7677039293536684	0	0	0.9289117591004383	0.41959793531268064	TNFRSF10B;MAP3K14
Macrophage M1 Lineage	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	MAP3K14
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	MAPKAPK2
Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	MAP3K14
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	MAPKAPK2
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	MAPKAPK2
Hashimoto's Thyroiditis	1/51	0.6417157078186339	0.7677039293536684	0	0	0.9849874055415617	0.43695016061192404	TNFRSF10B
Hodgkin Lymphoma	2/110	0.6464661311070917	0.7705995914966701	0	0	0.9116161616161617	0.3976783933077763	TNFRSF11A;MAP3K14
Acute Cytotoxic CD8+T-Cell Response against Melanocytes	1/52	0.6488637664596195	0.7705995914966701	0	0	0.9656245369684398	0.4176639924465685	MAP3K14
NF-kB Canonical Signaling	1/52	0.6488637664596195	0.7705995914966701	0	0	0.9656245369684398	0.4176639924465685	TNFRSF11A
Polycystic Ovary Syndrome	1/52	0.6488637664596195	0.7705995914966701	0	0	0.9656245369684398	0.4176639924465685	MAPKAPK2
Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles	1/53	0.6558695661624286	0.7775035584325518	0	0	0.9470063941096687	0.39944099175062525	STK11IP
T-Cell Receptor Signaling	1/54	0.6627359310657204	0.7793464780885493	0	0	0.9290908226795305	0.3822081396543251	MAP3K14
Atopic Dermatitis Onset	1/54	0.6627359310657204	0.7793464780885493	0	0	0.9290908226795305	0.3822081396543251	MAP3K14
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling	1/54	0.6627359310657204	0.7793464780885493	0	0	0.9290908226795305	0.3822081396543251	MAPKAPK2
Th2-Cell Function in Systemic Lupus Erythematosus	1/55	0.6694656294346574	0.7793464780885493	0	0	0.9118387909319899	0.3658985237407251	MAP3K14
NFKB Signaling Activation by Blocking of Tumor Suppressors	1/55	0.6694656294346574	0.7793464780885493	0	0	0.9118387909319899	0.3658985237407251	TNFRSF11A
Apoptosis and Immediate Early Gene Activation in Epileptiform Disorders	1/55	0.6694656294346574	0.7793464780885493	0	0	0.9118387909319899	0.3658985237407251	BCL2L11
beta-Cell Destruction in Diabetes Mellitus Type 1	1/55	0.6694656294346574	0.7793464780885493	0	0	0.9118387909319899	0.3658985237407251	CRADD
Dendritic Cell Activation in Systemic Lupus Erythematosis	1/55	0.6694656294346574	0.7793464780885493	0	0	0.9118387909319899	0.3658985237407251	TREX1
Proteins Involved in Diabetes Mellitus Type 2	2/115	0.6703435577752536	0.7793464780885493	0	0	0.8710556896397604	0.34839172377034267	TXNIP;CCK
Neutrophil Chemotaxis	1/56	0.6760613746671302	0.7793464780885493	0	0	0.8952141057934508	0.35045073373694197	BAIAP2
TLR4 Signaling in Leukocytes	1/56	0.6760613746671302	0.7793464780885493	0	0	0.8952141057934508	0.35045073373694197	CD14
Crohn's Disease	1/56	0.6760613746671302	0.7793464780885493	0	0	0.8952141057934508	0.35045073373694197	CD14
Proteins Involved in Diabetic Nephropathy	3/175	0.6798856335343878	0.7793464780885493	0	0	0.8579629084486311	0.33102841318428655	TXNIP;ESAM;SH2B2
Proteins Involved in High-Grade Serous Ovarian Carcinoma	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	CCNE1
Neutrophil Activation via Adherence on Endothelial Cells	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	BAIAP2
Th2-Cell Function in Ulcerative Colitis	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MAP3K14
Th2-Cell Response in Asthma	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MAP3K14
Treg-Cell Activation in Diabetes Mellitus	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MAP3K14
Th2-Cell Differentiation	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MAP3K14
Angiogenesis in Endometriosis	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MAPKAPK2
Genes with Mutations Associated with Retinitis Pigmentosa	1/57	0.6825258266695731	0.7793464780885493	0	0	0.8791831594098597	0.3358083257258929	MERTK
Peripheral T-Cell Tolerance	1/58	0.6888615922729094	0.7797530523644739	0	0	0.8637147023730611	0.3219193477249307	TNFRSF10B
Treg-Cell Differentiation	1/58	0.6888615922729094	0.7797530523644739	0	0	0.8637147023730611	0.3219193477249307	MAP3K14
Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors	1/58	0.6888615922729094	0.7797530523644739	0	0	0.8637147023730611	0.3219193477249307	CDH1
CD4+ T-Cell Function Decline in HIV	1/58	0.6888615922729094	0.7797530523644739	0	0	0.8637147023730611	0.3219193477249307	MAP3K14
VEGF Signaling	1/58	0.6888615922729094	0.7797530523644739	0	0	0.8637147023730611	0.3219193477249307	MAPKAPK2
Proteins Involved in Glioblastoma	3/178	0.6909453631163144	0.7807562855317799	0	0	0.843124773960217	0.3116986150481275	CCND3;CDH1;NES
Proteins Involved in Psoriasis	1/59	0.6950712269866532	0.7827054231352296	0	0	0.848779640406497	0.3087359159638121	MAPKAPK2
Steroids Induced Cataract	1/59	0.6950712269866532	0.7827054231352296	0	0	0.848779640406497	0.3087359159638121	CDH1
Proteins Involved in Female Infertility	1/60	0.7011572356175692	0.784141539661501	0	0	0.834350851726935	0.29621383856647	CDH1
Proteins Involved in Multiple Myeloma	1/60	0.7011572356175692	0.784141539661501	0	0	0.834350851726935	0.29621383856647	TNFRSF11A
Th2-Cells Function in Systemic Scleroderma	1/60	0.7011572356175692	0.784141539661501	0	0	0.834350851726935	0.29621383856647	MAP3K14
Toll-like Receptors in Sterile Inflammation	1/60	0.7011572356175692	0.784141539661501	0	0	0.834350851726935	0.29621383856647	CD14
Proteins Involved in Periodontitis	1/61	0.7071220732211568	0.7871227454491506	0	0	0.8204030226700252	0.28431227903304046	CD14
T-lymphoid precursor cell -> CD8+ Naive T-cell Surface Expression Markers	1/61	0.7071220732211568	0.7871227454491506	0	0	0.8204030226700252	0.28431227903304046	CD52
CD8+ T-Cell Activation	1/62	0.7129681463695063	0.7871227454491506	0	0	0.8069124994838337	0.2729934547505317	MAP3K14
Treg-Cell Function in Diabetes Mellitus Type 1	1/62	0.7129681463695063	0.7871227454491506	0	0	0.8069124994838337	0.2729934547505317	MAP3K14
T-Cell Dependent B-Cell Activation	1/63	0.7186978139086827	0.7871227454491506	0	0	0.7938571544649387	0.2622223672940164	MAP3K14
Th17-Cell Differentiation	1/63	0.7186978139086827	0.7871227454491506	0	0	0.7938571544649387	0.2622223672940164	MAP3K14
IDO1 in Cancer Immune Escape	1/63	0.7186978139086827	0.7871227454491506	0	0	0.7938571544649387	0.2622223672940164	MAP3K14
Metabolic Reprogramming in Cancer: Overview	1/63	0.7186978139086827	0.7871227454491506	0	0	0.7938571544649387	0.2622223672940164	SLC16A3
Basophil Activation in Asthma	1/63	0.7186978139086827	0.7871227454491506	0	0	0.7938571544649387	0.2622223672940164	IFI30
Proteins Involved in non-Alcoholic Fatty Liver Disease	3/186	0.7190291379941992	0.7871227454491506	0	0	0.8059348412533721	0.26584034463238077	DGAT1;PLIN3;CD14
Th1-Cell Differentiation	1/64	0.7243133880555604	0.7871227454491506	0	0	0.7812162648434688	0.2519665598475267	MAP3K14
Myeloblast -> Neutrophil Surface Expression Markers	1/64	0.7243133880555604	0.7871227454491506	0	0	0.7812162648434688	0.2519665598475267	CD14
Cetuximab Resistance in Colorectal Cancer	1/64	0.7243133880555604	0.7871227454491506	0	0	0.7812162648434688	0.2519665598475267	CBL
Neutrophil Degranulation via FPR1/IL8	1/64	0.7243133880555604	0.7871227454491506	0	0	0.7812162648434688	0.2519665598475267	BAIAP2
Proteins Involved in Helicobacter Infections	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	CD14
Th17-Cell Differentiation in Asthma	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	MAP3K14
B-Cell Activation in Systemic Lupus Erythematosus	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	MAP3K14
Cardiomyocyte Hypertrophy	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	MAP3K14
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	CDH1
Natural Killer T-Cell Roles in Diabetes Mellitus Type 1	1/65	0.7298171349531568	0.7871227454491506	0	0	0.7689704030226701	0.2421958995608348	MAP3K14
Proteins Involved in Alzheimer's Disease	2/130	0.7341932127226259	0.7871227454491506	0	0	0.7683869949494949	0.2374185591355672	NAE1;CLU
Proteins Involved in Hepatocellular Carcinoma	2/130	0.7341932127226259	0.7871227454491506	0	0	0.7683869949494949	0.2374185591355672	CDKN1A;CCNE1
Neutrophil Recruitment and Priming	1/66	0.7352112760406944	0.7871227454491506	0	0	0.7571013369502034	0.232882380584004	CD14
Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis	1/66	0.7352112760406944	0.7871227454491506	0	0	0.7571013369502034	0.232882380584004	MAP3K14
Toll-like Receptor Independent Sterile Inflammation	1/66	0.7352112760406944	0.7871227454491506	0	0	0.7571013369502034	0.232882380584004	TXNIP
Vascular Endothelial Cell Activation by Cytokines	1/66	0.7352112760406944	0.7871227454491506	0	0	0.7571013369502034	0.232882380584004	MAP3K14
Neuroblastoma	2/131	0.7380517505219449	0.7875415913271478	0	0	0.7623913554146112	0.23156976746221436	CCNB1;MAP3K14
Alzheimer's Disease	1/67	0.7404979887866372	0.7875415913271478	0	0	0.7455919395465995	0.22399994696327624	KAT5
Skin Fibrosis	1/67	0.7404979887866372	0.7875415913271478	0	0	0.7455919395465995	0.22399994696327624	MAP3K14
Alveolar Epithelial Cell Dysfunction in COPD	1/67	0.7404979887866372	0.7875415913271478	0	0	0.7455919395465995	0.22399994696327624	CDKN1A
Proteins Involved in Myocardial Ischemia	4/252	0.7416419280289398	0.7875415913271478	0	0	0.7922875388897986	0.23680581555899652	GDF15;SERPINH1;TXNIP;S1PR2
Metabolic Effects of Oncogenes and Tumor Suppressor in Cancer Cells	1/68	0.7456794073518693	0.7905414204771036	0	0	0.7344261062445957	0.2155243326176546	DGAT1
B-Cells Function in Systemic Scleroderma	1/69	0.7507576236347545	0.7946330691718506	0	0	0.7235886798044154	0.20743291609968634	MAP3K14
Proteins Involved in Endometriosis	4/256	0.7526294889963104	0.7953232201387267	0	0	0.779550398839739	0.2215343619794559	CCNB1;CDH3;GDF15;CDH1
Cytokines Trigger Otitis Media	1/71	0.7606126108547155	0.8010216239750093	0	0	0.7028427491903563	0.1923196370374743	MAP3K14
Humoral Immunity in Vitiligo	1/71	0.7606126108547155	0.8010216239750093	0	0	0.7028427491903563	0.1923196370374743	MAP3K14
Proteins Involved in Systemic Lupus Erythematosus	1/72	0.765393361558943	0.8010216239750093	0	0	0.6929080781920743	0.1852596310723313	CORO1A
Th1-Cells Activation and Proliferation in Atherosclerosis	1/72	0.765393361558943	0.8010216239750093	0	0	0.6929080781920743	0.1852596310723313	MAP3K14
Alveolar Macrophages Dysfunction in COPD	1/72	0.765393361558943	0.8010216239750093	0	0	0.6929080781920743	0.1852596310723313	CD14
Lymphocyte Mediated Myocardial Injury in Myocarditis	1/72	0.765393361558943	0.8010216239750093	0	0	0.6929080781920743	0.1852596310723313	MAP3K14
NFKB Canonical Signaling Activation in Cancer	1/75	0.7791717011967811	0.8141345339427906	0	0	0.6647150929266799	0.16586226586927993	TNFRSF11A
Proteins Involved in Myocarditis	3/207	0.7833018596990304	0.8161276629901129	0	0	0.7221891288160834	0.1763854076694089	TREX1;TNFSF9;CLU
Mast-Cell Activation in Asthma	1/76	0.7835826948340654	0.8161276629901129	0	0	0.6558186397984886	0.1599401824481757	CEBPB
TGFB Family in Epithelial to Mesenchymal Transition in Cancer	1/80	0.8003650428975723	0.8322775246717976	0	0	0.6224850939004559	0.13861955707517684	CDH1
Atopic Dermatitis	1/81	0.8043537015214308	0.8350933334267084	0	0	0.6146725440806046	0.13382415780391016	CDH1
Proteins Involved in Neuroblastoma	3/216	0.8068904650272545	0.8363952038120348	0	0	0.691353182385452	0.1483418209454146	CDKN1A;CLU;NES
Osteoarthritis	1/82	0.8082628630996523	0.8364879154618625	0	0	0.6070528967254408	0.12922210430137304	MAP3K14
Proteins Involved in Osteoarthritis	1/86	0.8231356832316835	0.8491842808023063	0	0	0.5783671655060009	0.11257004658509545	CEBPB
Mast-Cell Activation via IgE Signaling	1/86	0.8231356832316835	0.8491842808023063	0	0	0.5783671655060009	0.11257004658509545	CEBPB
Smooth Muscle Cell Dysfunction in Pulmonary Hypertension	1/88	0.8301347447144849	0.8550519013488849	0	0	0.5650134630417789	0.10518700168852364	CDKN1A
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling	1/90	0.8368574969015976	0.857910515691575	0	0	0.5522599269804432	0.09835830900646256	S1PR2
T-Cell Cytotoxic Response against Melanocytes in Vitiligo	1/90	0.8368574969015976	0.857910515691575	0	0	0.5522599269804432	0.09835830900646256	MAP3K14
Epithelial to Mesenchymal Transition in Cancer: Overview	1/90	0.8368574969015976	0.857910515691575	0	0	0.5522599269804432	0.09835830900646256	CDH1
CD4+T-Cell Response in Celiac Disease	1/91	0.8401186744431207	0.8599016887549682	0	0	0.546095717884131	0.09513649165685531	MAP3K14
Proteins Involved in Astrocytoma	1/92	0.8433148216850359	0.8618201625997546	0	0	0.5400669859108146	0.09203548123973296	CDKN1C
Proteins Involved in Cataract	1/94	0.8495171731797978	0.8654456201769191	0	0	0.5283984724140733	0.08617498636875781	CDH1
B-Cell Chronic Lymphocytic Leukemia	1/94	0.8495171731797978	0.8654456201769191	0	0	0.5283984724140733	0.08617498636875781	CCND3
Proteins Involved in Chronic Obstructive Pulmonary Disease	2/170	0.8551079166740352	0.8697821554937145	0	0	0.5842352092352092	0.0914489349489821	MAFB;CD14
Proteins Involved in Osteoporosis	1/100	0.8666928654123558	0.8801927542817071	0	0	0.49622166246851385	0.07099473831435102	TNFRSF11A
Endometrial Cancer	1/106	0.8819125024818047	0.8942565343983463	0	0	0.46772220223101835	0.05877510916694406	CDH1
Hepatocellular Carcinoma	1/112	0.8953983526691599	0.9065213135718824	0	0	0.44230376472190075	0.04886862716604955	CDKN1A
Pancreatic Ductal Carcinoma	1/117	0.9054550059665678	0.9152816494421739	0	0	0.4231303743594198	0.04202433245220423	CDKN1A
Proteins Involved in Epilepsy	3/270	0.9072127165891416	0.9156388408918272	0	0	0.5499928886360403	0.053557388293712455	PRRT2;ST3GAL5;KLK8
Receptors and Adaptor Proteins Activated in Cancer	1/125	0.919577865840107	0.9266843408465993	0	0	0.3956691313886406	0.033173119855749035	MERTK
Nociception Expression Targets Signaling	1/143	0.9441297282945486	0.9499576895803173	0	0	0.34519459325220847	0.019845823388513782	MAPKAPK2
Proteins Involved in Age-Related Macular Degeneration	1/148	0.9495091729940099	0.9538982754885894	0	0	0.33336760396853954	0.017271804867498294	AOC3
Proteins Involved in Pulmonary Hypertension	1/165	0.9642201635932596	0.9671249071263723	0	0	0.29855010137003135	0.010877859530482167	CCK
Proteins Involved in Dilated Cardiomyopathy	1/167	0.9656415867166693	0.9671249071263723	0	0	0.29492276410427604	0.01031124948582883	CDH1
Proteins Involved in Arterial Hypertension	1/255	0.9942491417366099	0.9942491417366099	0	0	0.19187211170392113	0.0011066143689658016	SERPINA6
